Seizert Capital Partners, LLC Pet Iq, Inc. Transaction History

Seizert Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$15.93 - $22.26 $35,300 - $49,328	-2,216 Reduced 12.1%	16,105 $355,000
Q4 2023 Feb 07, 2024	SELL	$17.18 - $22.38 $87,703 - $114,249	-5,105 Reduced 21.79%	18,321 $361,000
Q3 2023 Nov 06, 2023	SELL	$15.0 - $20.71 $43,185 - $59,624	-2,879 Reduced 10.94%	23,426 $461,000
Q2 2023 Jul 27, 2023	BUY	$10.84 - $15.43 $117,332 - $167,014	10,824 Added 69.92%	26,305 $399,000
Q1 2023 May 09, 2023	BUY	$9.32 - $12.58 $144,282 - $194,750	15,481 New	15,481 $177,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.